1. Decreased LAG3 expression on T effector cells and regulatory T cells in SAA

   • Yingying Sun
   • Chunyan Liu
   • Zonghong Shao

   Original Article 12 August 2020 Pages: 757 - 763

   

2. Rituximab prolongs the time to relapse in patients with immune thrombotic thrombocytopenic purpura: analysis of off-label use in Japan

   • Masayuki Kubo
   • Kazuya Sakai
   • Masanori Matsumoto

   Original Article 27 August 2020 Pages: 764 - 772

   

3. High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study

   • Jie Ma
   • Lingling Fu
   • Runhui Wu

   Original Article 03 September 2020 Pages: 773 - 779

   

4. Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: a retrospective case series

   • Yuichi Sumii
   • Noboru Asada
   • Yoshinobu Maeda

   Original Article 12 August 2020 Pages: 780 - 786

   

5. Romiplostim is effective for eltrombopag-refractory aplastic anemia: results of a retrospective study

   • Masataka Ise
   • Hiromitsu Iizuka
   • Kensuke Usuki

   Original Article 02 September 2020 Pages: 787 - 794

   

6. Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells

   • Kentaro Kihira
   • Vipin Shankar Chelakkot
   • Hiroki Hori

   Original Article 30 August 2020 Pages: 795 - 806

   

7. Dose-adjusted EPOCH with or without rituximab for aggressive lymphoma patients: real world data

   • Shinichiro Matsuda
   • Ritsuro Suzuki
   • Junji Suzumiya

   Original Article 03 September 2020 Pages: 807 - 816

   

8. Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma

   • Yasuhiro Suzuki
   • Takahiro Yano
   • Hirokazu Nagai

   Original Article 04 September 2020 Pages: 817 - 824

   

9. Outcome of allogeneic hematopoietic stem cell transplantation for hypoplastic myelodysplastic syndrome

   • Ming Zhou
   • Liangliang Wu
   • Shunqing Wang

   Original Article 16 August 2020 Pages: 825 - 834

   

10. Bortezomib and cyclophosphamide based chemo-mobilization in multiple myeloma

    • Bhausaheb Bagal
    • Anant Gokarn
    • Navin Khattry

    Original Article 02 September 2020 Pages: 835 - 840

    

11. Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection

    • Yachiyo Kuwatsuka
    • Yoshiko Atsuta
    • Takahiro Fukuda

    Original Article 01 September 2020 Pages: 841 - 850

    

12. Involvement of oral bacteria and oral immunity as risk factors for chemotherapy-induced fever with neutropenia in patients with hematological cancer

    • Yuka Sogawa
    • Makoto Fukui
    • Daisuke Hinode

    Original Article 03 September 2020 Pages: 851 - 859

    

13. Successful management of hemodialysis-dependent refractory myeloma with modified daratumumab, bortezomib and dexamethasone regimen

    • Shinichi Mizuno
    • Chigusa Kitayama
    • Toshinobu Sato

    Case Report 24 July 2020 Pages: 860 - 863

    

14. Lymphoplasmacytic lymphoma in a patient with Birt–Hogg–Dubé syndrome

    • Keiji Kurata
    • Hisayuki Matsumoto
    • Hironobu Minami

    Case Report 12 August 2020 Pages: 864 - 870

    

15. Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient

    • Yuki Fujiwara
    • Ken-ichi Matsuoka
    • Yoshinobu Maeda

    Case Report 17 August 2020 Pages: 871 - 877

    

16. A family with an MYH9-related disorder with different phenotypes masquerading as immune thrombocytopaenia: an underreported disorder in Taiwan

    • Ying-Chih Huang
    • Yu-Hung Shih
    • Ming-Ching Shen

    Case Report 25 July 2020 Pages: 878 - 882

    

17. Immune thrombocytopenia in a patient with COVID-19

    • Emilie Deruelle
    • Omar Ben Hadj Salem
    • Matthieu Jamme

    Case Report 16 July 2020 Pages: 883 - 888

    

18. Resolution of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis associated with rapid immune reconstruction after a single course of CHOP therapy

    • Yui Chikagawa
    • Kazuki Hikishima
    • Shinji Nakao

    Case Report 28 July 2020 Pages: 889 - 893

    

19. Aberrant splicing due to a novel RPS7 variant causes Diamond-Blackfan Anemia associated with spontaneous remission and meningocele

    • Talia Akram
    • Ambrin Fatima
    • Niklas Dahl

    Case Report 09 August 2020 Pages: 894 - 899

    

20. Living-donor liver transplantation providing an adequate chemotherapy for a pediatric patient with anaplastic large cell lymphoma complicated with liver failure due to the aggravation of biliary hepatopathy by secondary hemophagocytic lymphohistiocytosis

    • Kenichi Sakamoto
    • Tomoo Osumi
    • Kimikazu Matsumoto

    Case Report 24 July 2020 Pages: 900 - 905

    

21. Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group

    • Sachie Kasai
    • Hidehiro Itonaga
    • Yasushi Miyazaki

    Correction 21 October 2020 Pages: 906 - 906

22. Retraction Note to: High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey

    • Sung-Won Kim
    • Yoshitaka Asakura
    • Takahiro Fukuda

    Retraction Note 08 October 2020 Pages: 907 - 907